Tag Archive for: Mid-Atlantic Biotherapeutics

SMITM CAPITAL MARKETS LTD. has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc., entailing a capital commitment of $5 million to fuel MABT’s groundbreaking efforts to combat rabies.